BG18600A3 - Метод за получаване на бета-арил-2-аминоалкокси стироли - Google Patents

Метод за получаване на бета-арил-2-аминоалкокси стироли

Info

Publication number
BG18600A3
BG18600A3 BG017594A BG1759470A BG18600A3 BG 18600 A3 BG18600 A3 BG 18600A3 BG 017594 A BG017594 A BG 017594A BG 1759470 A BG1759470 A BG 1759470A BG 18600 A3 BG18600 A3 BG 18600A3
Authority
BG
Bulgaria
Prior art keywords
stirens
aminoalkoxy
aryl
obtaining beta
beta
Prior art date
Application number
BG017594A
Other languages
Bulgarian (bg)
English (en)
Inventor
Erich Mueller
Roland Maier
Willi Diederen
Original Assignee
Dr. Karl Thomae Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Karl Thomae Gmbh filed Critical Dr. Karl Thomae Gmbh
Publication of BG18600A3 publication Critical patent/BG18600A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20Hydroxy-styrenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
BG017594A 1969-08-05 1970-07-22 Метод за получаване на бета-арил-2-аминоалкокси стироли BG18600A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (de) 1969-08-05 1969-08-05 ß-Aryl-2-aminoalkoxy-styrole und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
BG18600A3 true BG18600A3 (bg) 1975-02-25

Family

ID=5741970

Family Applications (6)

Application Number Title Priority Date Filing Date
BG017594A BG18600A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета-арил-2-аминоалкокси стироли
BG015253A BG18599A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета-арил-2-аминоалкоксистироли
BG017598A BG17952A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета- арил-2- аминоалктлкокси - стироли
BG017595A BG20095A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на б-арил-2-аминоалкокси стироли
BG017596A BG17950A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета- арил-2- аминалкокси- стироли
BG017597A BG17951A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета- арил-2- аминоалокси- стироли

Family Applications After (5)

Application Number Title Priority Date Filing Date
BG015253A BG18599A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета-арил-2-аминоалкоксистироли
BG017598A BG17952A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета- арил-2- аминоалктлкокси - стироли
BG017595A BG20095A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на б-арил-2-аминоалкокси стироли
BG017596A BG17950A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета- арил-2- аминалкокси- стироли
BG017597A BG17951A3 (bg) 1969-08-05 1970-07-22 Метод за получаване на бета- арил-2- аминоалокси- стироли

Country Status (25)

Country Link
JP (6) JPS4941433B1 (fr)
KR (1) KR780000113B1 (fr)
AT (5) AT302346B (fr)
BE (1) BE754405A (fr)
BG (6) BG18600A3 (fr)
CH (6) CH548982A (fr)
CS (6) CS170538B2 (fr)
DE (1) DE1939809B2 (fr)
DK (1) DK139717B (fr)
ES (6) ES382427A1 (fr)
FI (1) FI54912C (fr)
FR (1) FR2068463B1 (fr)
GB (1) GB1307436A (fr)
HU (1) HU163185B (fr)
IE (1) IE34634B1 (fr)
IL (1) IL35047A (fr)
NL (1) NL7011590A (fr)
NO (1) NO135243C (fr)
PH (1) PH9520A (fr)
PL (2) PL78370B1 (fr)
RO (5) RO57793A (fr)
SE (1) SE382211B (fr)
SU (5) SU439966A3 (fr)
YU (2) YU198170A (fr)
ZA (1) ZA705411B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (fr) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (ja) * 1978-03-09 1985-10-11 三菱化学株式会社 ω−アミノアルコキシスチルベン類及びその酸付加塩
DE2818765A1 (de) 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE2818998A1 (de) * 1978-04-29 1979-11-15 Basf Ag 3-alkyl-5-(2-hydroxy-styryl)-isoxazole und verfahren zu ihrer herstellung
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943406A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
DE2943405A1 (de) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols
DE3006809A1 (de) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
JPS5874379U (ja) * 1981-11-16 1983-05-19 富士通株式会社 電子装置
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
JP6339010B2 (ja) 2011-06-10 2018-06-06 ザ プロクター アンド ギャンブル カンパニー 吸収性物品の吸収性構造体
CN105816277A (zh) 2011-06-10 2016-08-03 宝洁公司 一次性尿布
CN103596535B (zh) 2011-06-10 2015-11-25 宝洁公司 用于一次性吸收制品的吸收芯
PL2740449T3 (pl) 2012-12-10 2019-07-31 The Procter & Gamble Company Artykuł chłonny o wysokiej zawartości materiału chłonnego
EP3284450B1 (fr) 2013-06-14 2020-11-25 The Procter & Gamble Company Article absorbant et noyau absorbant formant des canaux lorsqu'il est humide
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (fr) 2013-09-19 2021-12-29 The Procter & Gamble Company Noyaux absorbants ayant des zones exemptes de matériau
PL2886092T3 (pl) 2013-12-19 2017-03-31 The Procter And Gamble Company Wkłady chłonne z obszarami tworzącymi kanały i zgrzewami osłony c

Also Published As

Publication number Publication date
RO57793A (fr) 1975-03-15
RO58837A (fr) 1975-09-15
KR780000113B1 (en) 1978-04-15
CS170533B2 (fr) 1976-08-27
CS170538B2 (fr) 1976-08-27
SU432712A3 (fr) 1974-06-15
HU163185B (fr) 1973-06-28
NO135243C (fr) 1977-03-09
RO58861A2 (fr) 1975-06-30
GB1307436A (en) 1973-02-21
ES382428A1 (es) 1972-11-16
FI54912C (fi) 1979-04-10
ES382430A1 (es) 1972-12-01
CH548368A (de) 1974-04-30
PL93130B1 (fr) 1977-05-30
JPS4941433B1 (fr) 1974-11-08
FI54912B (fi) 1978-12-29
DE1939809C3 (fr) 1979-01-11
RO57548A (fr) 1975-02-15
IL35047A0 (en) 1970-10-30
AT301565B (de) 1972-09-11
ES382425A1 (es) 1972-11-16
BG17950A3 (bg) 1974-03-05
IE34634L (en) 1971-02-05
SE382211B (sv) 1976-01-19
AT303055B (de) 1972-11-10
AT302344B (de) 1972-10-10
ZA705411B (en) 1971-05-27
PL78370B1 (fr) 1975-06-30
FR2068463A1 (fr) 1971-08-27
YU198170A (en) 1979-07-10
JPS5113150B1 (fr) 1976-04-26
DK139717C (fr) 1979-09-17
BE754405A (fr) 1971-02-04
NL7011590A (fr) 1971-02-09
CS170536B2 (fr) 1976-08-27
PH9520A (en) 1976-01-09
IL35047A (en) 1973-05-31
CS170537B2 (fr) 1976-08-27
CH548981A (de) 1974-05-15
ES382426A1 (es) 1972-11-16
CS170535B2 (fr) 1976-08-27
ES382429A1 (es) 1972-11-16
BG17951A3 (bg) 1974-03-05
JPS5113148B1 (fr) 1976-04-26
CH548982A (de) 1974-05-15
AT302346B (de) 1972-10-10
JPS5113147B1 (fr) 1976-04-26
YU37478A (en) 1979-07-10
SU439965A3 (ru) 1974-08-15
BG18599A3 (bg) 1975-02-25
BG17952A3 (bg) 1974-03-05
RO57794A (fr) 1975-06-15
AT302345B (de) 1972-10-10
FR2068463B1 (fr) 1974-08-30
JPS5113146B1 (fr) 1976-04-26
CS170534B2 (fr) 1976-08-27
JPS5113149B1 (fr) 1976-04-26
SU450398A3 (ru) 1974-11-15
IE34634B1 (en) 1975-07-09
CH548367A (de) 1974-04-30
NO135243B (fr) 1976-11-29
SU428597A3 (ru) 1974-05-15
SU439966A3 (ru) 1974-08-15
CH548366A (de) 1974-04-30
BG20095A3 (bg) 1975-10-30
ES382427A1 (es) 1972-11-16
DK139717B (da) 1979-04-02
CH548983A (de) 1974-05-15
DE1939809B2 (de) 1978-04-13
DE1939809A1 (de) 1971-02-18

Similar Documents

Publication Publication Date Title
BG17583A3 (bg) Метод за получаване на n- бензилимидозоли с антимикотично действие
BG17950A3 (bg) Метод за получаване на бета- арил-2- аминалкокси- стироли
BG17506A3 (bg) Метод за получаване на 1- фенокси-2- хидрокси- з- циклоалкиламино- пропани
BG17956A3 (bg) Метод за получаване на нифтилал- киламини
BG17005A3 (bg) Метод за получаване на нови- 5- нитрофурилови производни
BG17579A3 (bg) Метод за получаване на имидазолиди - нови производни
BG17802A3 (bg) Метод за получаване на диалиламиноалканоиламиди
BG16333A3 (bg) Метод за получаване на гама-цианбутиралдимини
BG17559A3 (bg) Метод за получаване на нови неринфолинови производни
BG18180A3 (bg) Метод за получаване на нови амино-пропиофенони
BG17601A3 (bg) Метод за получаане на нови бензодиазепанови производни
BG17974A3 (bg) Метод за получаване на тетрахидро- бензиазепинони
BG17531A3 (bg) Метод за получаване на алкиламинопропани
BG17536A3 (bg) Метод за получаване на заместени ациланилиди
BG17313A3 (bg) Метод за получаване на s-нитрофурилови ппроизводни
BG17306A3 (bg) Метод за получаване на нови карденолид-гликозиди
BG17006A3 (bg) Метод за получаване на нови -5- нитрооурилови производни
BG17611A3 (bg) Метод за получаване на нови 5- нитро- фурилови производни
BG16325A3 (bg) Метод за получаване на гама-цианобутиралдехид
BG17957A3 (bg) Метод за получаване на нафтилалкиламини
BG17556A3 (bg) Метод за получаване на заместени 2- азабициклоалкани
BG17765A3 (bg) Метод за получаване на нови сулфинилкарбамиди
SU457219A3 (ru) Способ получени фенацетилгуанидинов
BG17757A3 (bg) Метод за получаване на нови заместени полиметилендиамини
BG27072A3 (bg) Метод за получаване на чист ацетонцианхидрин